Daniel G. Aaron, MD, JD
@medlawdan
Law prof @SJQuinney. Public health, law, FDA, inequity. 🏳️🌈 He, him. Views are my own. RT ≠ endorse
ID: 774979029699092480
11-09-2016 14:32:53
7,7K Tweet
3,3K Followers
1,1K Following
My new piece on the litigation over vapes. One angle: SCt has increasingly said that agencies should be subject to presidential control, but here 5CA dings FDA for flip-flopping in their handling of an industry when the presidency changed. Daniel G. Aaron, MD, JD nejm.org/doi/full/10.10…
Daniel G. Aaron, MD, JD (Daniel G. Aaron, MD, JD) discusses a Supreme Court case about e-cigarettes that could have implications for the FDA’s authority and for public health. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (Stephen Morrissey): nej.md/40THKOD
Closing strong at Seton Hall Center for Health & Pharmaceutical Law’s 9th Annual Health Law Works-in-Progress Retreat with Daniel G. Aaron, MD, JD’s “Privatization, Cancer, and the Individualization of Social Problems” with commentators Prof. Valerie Blake of @UTKLaw & Gregg Bloche.
Gotta love the Seton Hall Center for Health & Pharmaceutical Law Book Club! In our annual health law WIP workshop we give away to participants works of fiction that our center members like. Great to have Daniel G. Aaron, MD, JD Wendy Netter Epstein Jamelia Morgan Lewis Grossman Nathan Cortez Tammi Etheridge & others Seton Hall Law!
Perspective by Daniel G. Aaron, MD, JD (Daniel G. Aaron, MD, JD), and Christopher Robertson, JD, PhD (Christopher Robertson): E-Cigarettes at the Supreme Court — Potential Implications for the FDA and Public Health nej.md/4g7Wb60 #HealthPolicy
What possible implications could the Supreme Court’s decision on a case about e-cigarettes have on the FDA and public health? Daniel G. Aaron, MD, JD (Daniel G. Aaron, MD, JD), addresses that question in a new interview. Listen to the full interview: nej.md/40THKOD Read the
As NCAA and others hasten to comply with recent Executive Order, this excellent article by Daniel G. Aaron, MD, JD and Craig Konnoth is a salutary reminder and problematization of the role of medicine in reinforcing social norms nejm.org/doi/full/10.10…
Perspective by Daniel G. Aaron, MD, JD (Daniel G. Aaron, MD, JD), and Craig Konnoth, JD (Craig Konnoth): The Cass Review on gender-affirming care, which has been used to justify bans in U.S. states, transgresses medical law, policy, and practice, which puts it at odds with mainstream U.S.
In a new NEJM article, Prof. Daniel G. Aaron, MD, JD & co-author Christopher Robertson examine a pending SCOTUS case brought by the FDA against e-cigarette manufacturers. They say a ruling against the FDA could have major implications for the agency—and for public health. nejm.org/doi/full/10.10…
Professor Daniel G. Aaron, MD, JD, along with Jonathan Feingold and Dr. Quang-Tuyen Nguyen, argue that ending DEI in healthcare can diminish care and run the risk of lawsuits in this Bloomberg Law article. news.bloomberglaw.com/business-and-p…
In their new Forefront article, Kyle A. Gavulic, Carson Ferrara, Daniel G. Aaron, MD, JD, and Gilbert Gonzales, PhD, MHA of Yale School of Medicine, Yale School of Public Health, Utah Law, and @VUHealthPol empirically present the progress that the Biden administration made by executive order for civil rights, health equity, and the social
Professor Daniel G. Aaron, MD, JD, a health law expert, is quoted in this Mother Jones article about the Department of Health and Human Services (HHS) report on gender-affirming youth care. motherjones.com/politics/2025/…
Pointing to unchecked lab-developed tests and accelerated drug pathways, Daniel G. Aaron, MD, JD of @SJQuinney argues corporate influence has sidelined FDA oversight and calls on lawmakers to restore full premarket review authority. buff.ly/LftLmpq
Associate Professor Daniel G. Aaron, MD, JD published a new paper in JGIM Journal of General Internal Medicine with rising 3L Sonya Chechik about the Supreme Court's new loophole to the 6-year time limit to sue federal agencies.
